文献速递中毒与环境急症消化、代谢与肾脏急症

两袋法与三袋法乙酰半胱氨酸方案治疗对乙酰氨基酚中毒的比较:系统评价与Meta分析

Comparison of two-bag and three-bag acetylcysteine regimens in the treatment of paracetamol poisoning: a systematic review and meta-analysis.
PubMed 文献 · Clin Toxicol (Phila) · 2025-02-27
一句话结论两袋法乙酰半胱氨酸方案在肝毒性方面不劣于三袋法,且非过敏反应性类过敏反应及其他不良事件风险显著降低(OR 0.24)。

该系统评价与Meta分析检索Medline/PubMed、Google、Google Scholar、Cochrane Library、Embase和Toxnet(2022年5月23日),纳入8项研究,其中6项比较两袋法与三袋法乙酰半胱氨酸方案。主要结局肝毒性方面,两袋法相对风险与三袋法无差异(OR 0.88;95%CI 0.72-1.08;P=0.23);次要结局非过敏反应性类过敏反应及其他不良事件方面,两袋法风险显著降低(OR 0.24;95%CI 0.17-0.35;P<0.0001)。作者认为两袋法是急性对乙酰氨基酚中毒安全有效的治疗方案,并建议进一步开展随机对照试验比较更简化的单袋法。

要点

  • 两袋法(乙酰半胱氨酸200 mg/kg持续4 h,继以100 mg/kg持续16 h)与三袋法相比,肝毒性相对风险无差异(OR 0.88;95%CI 0.72-1.08;P=0.23)。
  • 两袋法较三袋法显著降低非过敏反应性类过敏反应及其他不良事件风险(OR 0.24;95%CI 0.17-0.35;P<0.0001)。
  • 6项比较两袋法与三袋法的研究在肝毒性方面无异质性(Q(5)=1.11;P=0.95;I2=0%;95%CI 0%-74.6%)。
  • 6项研究在非过敏反应性类过敏反应及不良事件方面异质性I2=50.7%(Q(5)=10.15;P=0.07;95%CI 0%-80.4%)。
  • 作者认为两袋法是急性对乙酰氨基酚中毒安全有效的治疗,并建议进一步开展随机对照试验比较单袋法等更简化方案。

适用人群与场景

  • 急性对乙酰氨基酚(paracetamol)中毒患者,研究纳入使用经美国食品药品监督管理局(FDA)批准及未经FDA批准的乙酰半胱氨酸方案的研究。
  • 排除病例报告、综述文章和动物研究。

处置流程与药物剂量

  • 常见的两袋法方案:乙酰半胱氨酸200 mg/kg持续4 h静脉输注,继以100 mg/kg持续16 h输注。
  • 其他4项研究采用改良两袋输注方案,输注时长或剂量各有不同。

研究设计与关键结果

  • 系统评价与Meta分析:共检索到657条引文,643项研究经筛选后46项符合全文审查标准,最终8项符合研究标准。
  • 8项研究中,4项采用改良两袋输注方案(输注时长或剂量不同),4项采用相同的「常见」两袋方案(乙酰半胱氨酸200 mg/kg持续4 h,继以100 mg/kg持续16 h)。
  • 6项比较两袋法与三袋法的研究纳入随机效应模型Meta分析。
  • 肝毒性方面6项研究无异质性:Q(5)=1.11;P=0.95;I2=0%;95%CI 0%-74.6%。
  • 非过敏反应性类过敏反应及不良事件方面6项研究异质性:Q(5)=10.15;P=0.07;I2=50.7%;95%CI 0%-80.4%。
  • 与三袋法相比,两袋法肝毒性相对风险无差异(OR 0.88;95%CI 0.72-1.08;P=0.23)。
  • 与三袋法相比,两袋法非过敏反应性类过敏反应及其他不良事件风险显著降低(OR 0.24;95%CI 0.17-0.35;P<0.0001)。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,遵循PRISMA指南,采用固定效应Meta分析(R包meta),异质性用Cochran Q检验和I2统计量评估。
  • 局限:作者认为需要进一步开展随机对照试验,以比较更简化的单袋法等方案。

对床旁实践的改变

  • 作者认为两袋法乙酰半胱氨酸方案是急性对乙酰氨基酚中毒安全有效的治疗,较三袋法显著减少非过敏反应性类过敏反应,且在肝毒性方面不劣于三袋法。
  • 作者认为该信息对许多机构的实践具有改变意义,并建议进一步开展随机对照试验比较单袋法等更简化方案。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Worldwide, paracetamol poisoning is a common cause of acute liver failure and referral to transplant centers. Acetylcysteine has long been the mainstay of treatment, but recent literature suggests that a simplification of the "three-bag" method may decrease adverse effects. Our primary hypothesis is that a simplified dosing regimen (two-bag regimen) is non-inferior to the three-bag method in preventing liver injury. Our secondary hypothesis is that a simplified regimen will have lower rates of adverse effects.

METHODS: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we searched Medline/PubMed, Google, Google Scholar, Cochrane Library, Embase and Toxnet on May 23, 2022. The Medical Subject Headings terms were NAC, acetaminophen toxicity, acetyl-cysteine, N-acetylcysteine, paracetamol, APAP, 2-bag, and 3-bag. The Embase terms were acetylcysteine, NAC, 2-bag, two bag, 3-bag, three bag, simplified dosing, acetaminophen, Tylenol®, paracetamol, APAP, drug overdose, poisoning, and overdose. Studies included both non-United States Food and Drug Administration-approved and United States Food and Drug Administration-approved acetylcysteine regimens. Case reports, review articles, and animal studies were excluded. Two authors independently reviewed each study using Rayyan QCRI to determine if the studies met search criteria while blinded to the selections of each other. The two authors discussed until reaching a consensus. We used a primary outcome of non-inferiority of hepatotoxicity. We used secondary outcomes of non-allergic anaphylactoid reactions and adverse events. We conducted a fixed-effect meta-analysis using R package meta. To visually summarize the meta-analysis results, we also produced forest plots. We used Cochran's Q test and I2 statistical analysis to assess heterogeneity between the studies.

RESULTS: Our search resulted in 657 total citations, which were reduced to unique citations. Of the 643 studies, 46 met the criteria for full text review, and eight met the study criteria. Of the eight studies investigating a simplified acetylcysteine regimen, four studies utilized some form of a modified two-bag infusion regimen, varying in duration or dosing of infusions, and four studies shared the same "common" two-bag treatment, a regimen that delivers acetylcysteine 200 mg/kg over 4 h, followed by 100 mg/kg acetylcysteine over 16 h. The six studies comparing a two-bag dosing regimen to the three-bag technique were utilized for our random effect model meta-analysis. We found no significant heterogeneity amongst the six studies for either hepatotoxicity (Q(5) = 1.11; P = 0.95; I2 = 0%; 95% CI: 0%-74.6%) or non-allergic anaphylactoid reactions and adverse events (Q(5) = 10.15; P = 0.07; I2 = 50.7%; 95% CI: 0%-80.4%). Compared to the traditional three-bag dosing regimen, the two-bag method did not demonstrate a difference in relative risk for hepatotoxicity (OR: 0.88; 95% CI: 0.72-1.08; P = 0.23) but did demonstrate a significantly decreased likelihood of non-allergic anaphylactoid reactions and other adverse events (OR: 0.24; 95% CI: 0.17-0.35; P <0.0001).

DISCUSSION: The two-bag method is a safe and effective treatment for acute paracetamol poisoning. The two-bag regimen is correlated with a significant reduction in non-allergic anaphylactoid reactions, compared to the three-bag method, and is non-inferior with respect to hepatotoxicity. While we feel this information is practice changing for many, further research in the form of a randomized control trial would be beneficial to compare even more abbreviated methods such as a "single bag method."

CONCLUSION: Two-bag acetylcysteine dosing regimens appear to be non-inferior to the three-bag method with respect to hepatotoxicity, and result in fewer anaphylactoid, cutaneous, and gastrointestinal reactions.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Nakatsu L, Lopez JR, Garcia CM, et al. Comparison of two-bag and three-bag acetylcysteine regimens in the treatment of paracetamol poisoning: a systematic review and meta-analysis. Clin Toxicol (Phila). 2025. PMID: 40013897. doi:10.1080/15563650.2025.2456116

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。